Background and aims: According to the literature, 14–46% of subjects clear hepatitis C virus (HCV) from blood after infection. Controversy exists about sex differences in HCV clearance rates.
Patients and methods: We compared HCV clearance in males and females using data from a large population based study on HCV infection in Egypt. Definitions used in the paper were: cleared HCV infection (positive HCV antibody and negative HCV RNA test results) and chronic HCV infection (positive HCV antibody and positive HCV RNA test results). The study sample included 4720 village residents aged 18–65 years recruited through home based visits (n = 2425) or voluntary screening (n = 2295).
Results: Overall, HCV antibody prevalence was 910/4720 (19.3% (95% confidence interval 18.2–20.4)). Of those with HCV antibodies (n = 910), 61.5% had chronic HCV infection. Compared with males, females were more likely to have cleared the virus (44.6% v 33.7%, respectively; p = 0.001). Control for age, schistosomiasis history, iatrogenic exposures, and sexual exposure to HCV did not alter the positive association between female sex and viral clearance.
Conclusion: This study provides strong evidence in favour of a higher HCV clearance rate in females compared with males.
- HCV, hepatitis C virus
- ALT, alanine aminotransferase
- OR, odds ratio
- HIV, human immunodeficiency virus
- hepatitis C virus
- natural history
Statistics from Altmetric.com
Published online first 24 January 2006
Funding was provided by the European Community (INCO-MED Programme: Viral Hepatitis Surveillance in Mediterranean Countries, Contract ICA3-CT-2000-30011) and Agence Nationale de Recherche sur le SIDA, France (ANRS 1211).
Conflict of interest: None declared.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.